What non-taxane chemotherapy, if any, would you give with trastuzumab in adjuvant setting of a pT1cN0 HER2+ breast CA in patients with hyperbilirubinemia >3 due to cirrhosis?
Answer from: Medical Oncologist at Academic Institution
In this difficult case, the risks of any therapy may outweigh the benefits. Depending on the patient's age, etiology of the cirrhosis, and eligibility for liver transplant, I might think about single-agent trastuzumab.
Comments
Medical Oncologist at University of Florida Could vinorelbine be added?
Could vinorelbine be added?